呼出气分析技术在呼吸系统疾病中的应用及进展

doi:10.3969/j.issn.1006-5725.2024.22.002

Abstract

Abstract:

Exhaled breath analysis technology is a non-invasive， painless， safe， convenient， and efficient detection method. It holds great promise in disease screening， clinical diagnosis， assessment of disease severity， formulation of treatment plans， and prediction of disease prognosis. In recent years， this technology has rapidly advanced and has become an important tool in the management of respiratory system diseases. This article aims to provide a brief overview of the clinical applications and research progress of common exhaled breath analysis technologies in respiratory system diseases such as airway chronic inflammatory diseases and airway infectious diseases.

Key words: exhaled breath analysis technology, metabolomics, respiratory system diseases, COVID-19

CLC Number:

Donglu LIANG,Libing. MA. Application and progress of exhaled breath analysis technology in respiratory system diseases[J]. The Journal of Practical Medicine, 2024, 40(22): 3124-3129.

References 42

1	GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations， 1990-2021： A systematic analysis for the Global Burden of Disease Study 2021［J］. Lancet， 2024， 403（10440）：2100-2132.
2	中国医药教育协会慢性气道疾病专业委员会，中国哮喘联盟. 呼出气一氧化氮检测及其在气道疾病诊治中应用的中国专家共识［J］. 中华医学杂志， 2021，101（38）：3092-3114.
3	KREIT J W. Volume Capnography in the Intensive Care Unit：Potential Clinical Applications［J］. Ann Am Thorac Soc， 2019，16（4）：409-420. doi:10.1513/annalsats.201807-502cme doi: 10.1513/annalsats.201807-502cme
4	GRASSIN-DELYLE S， ROQUENCOURT C， MOINE P， et al. Metabolomics of exhaled breath in critically ill COVID-19 patients：A pilot study［J］. EBioMedicine， 2021，63：103154. doi:10.1016/j.ebiom.2020.103154 doi: 10.1016/j.ebiom.2020.103154
5	RICCO M， ZANIBONI A， SATTA E， et al. Potential Use of Exhaled Breath Condensate for Diagnosis of SARS-CoV-2 Infections：A Systematic Review and Meta-Analysis［J］. Diagnostics （Basel）， 2022，12（9）：2245. doi:10.3390/diagnostics12092245 doi: 10.3390/diagnostics12092245
6	中华医学会呼吸病学分会哮喘学组. 支气管激发试验临床应用中国专家共识（2024版）［J］. 中华医学杂志， 2024，104（22）：2031-2040.
7	缪晔红，沈莹莹，魏源，等. FeNO、外周血EOS计数及血清总IgE对支气管哮喘的联合诊断价值探讨［J］. 国际呼吸杂志， 2022，42（8）：583-588.
8	SONG W J， KIM H J， SHIM J S， et al. Diagnostic accuracy of fractional exhaled nitric oxide measurement in predicting cough-variant asthma and eosinophilic bronchitis in adults with chronic cough：A systematic review and meta-analysis［J］. J Allergy Clin Immunol， 2017，140（3）：701-709. doi:10.1016/j.jaci.2016.11.037 doi: 10.1016/j.jaci.2016.11.037
9	张星慧，常晓悦. IL-8与FeNO在不同炎症表型的咳嗽变异性哮喘患者中的水平及临床意义［J］. 国际呼吸杂志， 2020，40（20）：1585-1591.
10	梁桂菊，陈碧，朱洁晨，等. 哮喘患者肺泡一氧化氮与小气道功能的相关性［J］. 实用医学杂志， 2022，38（6）：767-772.
11	ZENG G S， CHEN H， CHEN L C， et al. Clinical implications of concentration of alveolar nitric oxide in asthmatic and non-asthmatic subacute cough［J］. J Breath Res， 2021，16（1）. doi：10.1088/1752-7163/ac3616 . doi: 10.1088/1752-7163/ac3616
12	TURNER S， COTTON S， WOOD J， et al. Reducing asthma attacks in children using exhaled nitric oxide （RAACENO） as a biomarker to inform treatment strategy： A multicentre， parallel， randomised， controlled， phase 3 trial［J］. Lancet Respir Med， 2022，10（6）：584-592. doi:10.1016/s2213-2600(21)00486-0 doi: 10.1016/s2213-2600(21)00486-0
13	FANG C， YANG L J， CHEN X J， et al. A clinical investigation into the usefulness of fractional exhaled nitric oxide in guiding glucocorticoid therapy in children with bronchial asthma［J］. J Physiol Pharmacol， 2022，73（4）. doi：10.26402/jpp.2022.4.09 . doi: 10.26402/jpp.2022.4.09
14	HANIBUCHI M， MITSUHASHI A， KAJIMOTO T， et al. Clinical significance of fractional exhaled nitric oxide and periostin as potential markers to assess therapeutic efficacy in patients with cough variant asthma［J］. Respir Investig， 2023，61（1）：16-22. doi:10.1016/j.resinv.2022.10.006 doi: 10.1016/j.resinv.2022.10.006
15	IKWU I， NICOLAS L G， MEHARI A， et al. Fractional exhaled nitric oxide and mortality in asthma and chronic obstructive pulmonary disease in a national cohort aged 40 years and older［J］. Respir Med， 2022，198：106879. doi:10.1016/j.rmed.2022.106879 doi: 10.1016/j.rmed.2022.106879
16	SU K C， KO H K， HSIAO Y H， et al. Fractional Exhaled Nitric Oxide Guided-Therapy in Chronic Obstructive Pulmonary Disease：A Stratified， Randomized， Controlled Trial［J］. Arch Bronconeumol， 2022，58（8）：601-610. doi:10.1016/j.arbres.2021.11.013 doi: 10.1016/j.arbres.2021.11.013
17	ZHANG C， ZHANG M， WANG Y， et al. Diagnostic value of fractional exhaled nitric oxide in differentiating the asthma-COPD overlap from COPD： A systematic review and meta-analysis［J］. Expert Rev Respir Med， 2022，16（6）：679-687. doi:10.1080/17476348.2022.2011221 doi: 10.1080/17476348.2022.2011221
18	MONEDEIRO F， MONEDEIRO-MILANOWSKI M， RATIU I A， et al. Needle Trap Device-GC-MS for Characterization of Lung Diseases Based on Breath VOC Profiles［J］. Molecules， 2021，26（6）：1789. doi:10.3390/molecules26061789 doi: 10.3390/molecules26061789
19	KIENHORST S， VAN AARLE M， JOBSIS Q， et al. The ADEM2 project： Early pathogenic mechanisms of preschool wheeze and a randomised controlled trial assessing the gain in health and cost-effectiveness by application of the breath test for the diagnosis of asthma in wheezing preschool children［J］. BMC Public Health， 2023，23（1）：629. doi:10.1186/s12889-023-15465-6 doi: 10.1186/s12889-023-15465-6
20	SCHLEICH F N， ZANELLA D， STEFANUTO P H， et al. Exhaled Volatile Organic Compounds Are Able to Discriminate between Neutrophilic and Eosinophilic Asthma［J］. Am J Respir Crit Care Med， 2019，200（4）：444-453. doi:10.1164/rccm.201811-2210oc doi: 10.1164/rccm.201811-2210oc
21	BRINKMAN P， WAGENER A H， HEKKING P P， et al. Identification and prospective stability of electronic nose （eNose）-derived inflammatory phenotypes in patients with severe asthma［J］. J Allergy Clin Immunol， 2019，143（5）：1811-1820. doi:10.1016/j.jaci.2018.10.058 doi: 10.1016/j.jaci.2018.10.058
22	HOLZ O， WASCHKI B， WATZ H， et al. Breath volatile organic compounds and inflammatory markers in adult asthma patients：Negative results from the ALLIANCE cohort［J］. Eur Respir J， 2021，57（2）：2002127. doi:10.1183/13993003.02127-2020 doi: 10.1183/13993003.02127-2020
23	PERTZOV B， RONEN M， ROSENGARTEN D， et al. Use of capnography for prediction of obstruction severity in non-intubated COPD and asthma patients［J］. Respir Res， 2021，22（1）：154. doi:10.1186/s12931-021-01747-3 doi: 10.1186/s12931-021-01747-3
24	TALKER L， NEVILLE D， WIFFEN L， et al. Machine diagnosis of chronic obstructive pulmonary disease using a novel fast-response capnometer［J］. Respir Res， 2023，24（1）：150. doi:10.1080/15412555.2024.2321379 doi: 10.1080/15412555.2024.2321379
25	SUN X， YANG W， GONG S， et al. Diagnostic value of volumetric capnography in patients with chronic cough variant asthma［J］. Clinics （Sao Paulo）， 2020，75：e1662. doi:10.6061/clinics/2020/e1662 doi: 10.6061/clinics/2020/e1662
26	ABDULLAH A A， ZAHEDI F D， HUSAIN S， et al. Diagnostic Value and Clinical Application of Nasal Fractional Exhaled Nitric Oxide in Subjects with Allergic Rhinitis［J］. Am J Rhinol Allergy， 2023，37（3）：307-312. doi:10.1177/19458924221145084 doi: 10.1177/19458924221145084
27	HACCURIA A， Van MUYLEM A， MALINOVSCHI A， et al. Small airways dysfunction： The link between allergic rhinitis and allergic asthma［J］. Eur Respir J， 2018，51（2）：1701749. doi:10.1183/13993003.01749-2017 doi: 10.1183/13993003.01749-2017
28	DRAGONIERI S， QUARANTA V N， CARRATU P， et al. Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma［J］. Biomarkers， 2019， 24（1）：70-75. doi:10.1080/1354750x.2018.1508307 doi: 10.1080/1354750x.2018.1508307
29	GUEST C， DEWHIRST S Y， LINDSAY S W， et al. Using trained dogs and organic semi-conducting sensors to identify asymptomatic and mild SARS-CoV-2 infections： An observational study［J］. J Travel Med， 2022，29（3）：taac043.
30	SHARMA R， ZANG W， TABARTEHFARAHANI A， et al. Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant［J］. JAMA Netw Open， 2023， 6（2）：e230982. doi:10.1001/jamanetworkopen.2023.0982 doi: 10.1001/jamanetworkopen.2023.0982
31	MYERS R， RUSZKIEWICZ D M， MEISTER A， et al. Breath testing for SARS-CoV-2 infection［J］. EBioMedicine， 2023， 92：104584. doi:10.1016/j.ebiom.2023.104584 doi: 10.1016/j.ebiom.2023.104584
32	V R N， MOHAPATRA A K， V K U， et al. Post-COVID syndrome screening through breath analysis using electronic nose technology［J］. Anal Bioanal Chem， 2022，414（12）：3617-3624. doi:10.1007/s00216-022-03990-z doi: 10.1007/s00216-022-03990-z
33	RYAN D J， TOOMEY S， MADDEN S F， et al. Use of exhaled breath condensate （EBC） in the diagnosis of SARS-COV-2 （COVID-19）［J］. Thorax， 2021，76（1）：86-88. doi:10.1136/thoraxjnl-2020-215705 doi: 10.1136/thoraxjnl-2020-215705
34	BETANCOR D， VALVERDE-MONGUE M， GOMEZ-LOPEZ A， et al. Evaluation of Fractional Exhaled Nitric Oxide During SARS-CoV-2 Infection［J］. J Investig Allergol Clin Immunol， 2022， 32（4）：301-303. doi:10.18176/jiaci.0762 doi: 10.18176/jiaci.0762
35	LIOR Y， YATZKAN N， BRAMI I， et al. Fractional exhaled Nitric Oxide （FeNO） level as a predictor of COVID-19 disease severity［J］. Nitric Oxide， 2022，124：68-73. doi:10.1016/j.niox.2022.05.002 doi: 10.1016/j.niox.2022.05.002
36	KARAALI R， CAKIR A， BORA E S， et al. The Evaluation of End Tidal Carbon Dioxide Values in Intubated Patients with COVID-19［J］. Acta Biomed， 2022，93（1）：e2022032.
37	GRAF J， PEREZ R， LOPEZ R. Increased respiratory dead space could associate with coagulation activation and poor outcomes in COVID-19 ARDS［J］. J Crit Care， 2022，71：154095. doi:10.1016/j.jcrc.2022.154095 doi: 10.1016/j.jcrc.2022.154095
38	ZETOLA N M， MODONGO C， MATSIRI O， et al. Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples［J］. J Infect， 2017，74（4）：367-376. doi:10.1016/j.jinf.2016.12.006 doi: 10.1016/j.jinf.2016.12.006
39	SAKTIAWATI A， PUTERA D D， SETYAWAN A， et al. Diagnosis of tuberculosis through breath test：A systematic review［J］. EBioMedicine， 2019，46：202-214. doi:10.1016/j.ebiom.2019.07.056 doi: 10.1016/j.ebiom.2019.07.056
40	CORONEL T R， IJDEMA D， GOMEZ C， et al. The electronic nose as a rule-out test for tuberculosis in an indigenous population［J］. J Intern Med， 2021，290（2）：386-391. doi:10.1111/joim.13281 doi: 10.1111/joim.13281
41	LOPEZ J W， LOADER M I， SMITH D， et al. Exhaled Nitric Oxide is Not a Biomarker for Pulmonary Tuberculosis［J］. Am J Trop Med Hyg， 2018，98（6）：1637-1639. doi:10.4269/ajtmh.17-0425 doi: 10.4269/ajtmh.17-0425
42	AHMED W M， FENN D， WHITE I R， et al. Microbial Volatiles as Diagnostic Biomarkers of Bacterial Lung Infection in Mechanically Ventilated Patients［J］. Clin Infect Dis， 2023， 76（6）：1059-1066. doi:10.1093/cid/ciac859 doi: 10.1093/cid/ciac859

[1]	Qingwen WANG,Shuya ZHANG,Weilin XIONG,Xiaolei HU,Ziwei LI,Qingyin. GUO. Characteristics of oral flora and its metabolites in children with henoch⁃schonlein purpura [J]. The Journal of Practical Medicine, 2024, 40(9): 1244-1250.
[2]	Na LI,Yihua BAI,Hongying JIANG,Feng ZHANG,Meng LI,Jiao YANG. Frailty of patients with long⁃term maintenance dialysis and its influencing factors [J]. The Journal of Practical Medicine, 2024, 40(3): 330-335.
[3]	LEI Yu, HU Yaxin, YU Lei, CHENG Mingliang, CHENG Zhuo, CONG Shuo, PU Qian, ZHENG Lin. . Effect of intrahepatic cholestasis on bile acid spectrum and intestinal flora in ileocecum of mice [J]. The Journal of Practical Medicine, 2023, 39(10): 1232-1236.
[4]	LI Li, ZHOU Jiahe, LI Mojuan, ZHONG Minglin, ZHANG Xiaowei, XU Qiuyi, LIANG Li⁃ anyun.. A frontier review and an outlook on epigenetics，metabolomics，and gut microbiota mechanism of polycystic ovary syndrome [J]. The Journal of Practical Medicine, 2022, 38(16): 1987-1992.
[5]	YE Mingjun, DAI Yong, TANG Donge, LI Qiang, YIN Lianghong.. Research progress of metabonomics in peritoneal dialysis [J]. The Journal of Practical Medicine, 2022, 38(1): 1-6.
[6]	LI Ying, LI Canwei, FAN Mengran, LIU Wei⁃ hong, GAO Pengfei. Metabolomics research progress on alcoholic liver disease [J]. The Journal of Practical Medicine, 2021, 37(7): 944-947.

Application and progress of exhaled breath analysis technology in respiratory system diseases

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 42

Related Articles 6

Recommended Articles

Metrics

Comments